Ablative therapies for intrahepatic cholangiocarcinoma

作     者：Antonio Giorgio Pietro Gatti Paolo Matteucci Valentina Giorgio 

作者机构：Interventional Ultrasound UnitTortorella Clinical HospitalSalernoItaly Internal Medicine DivisionOstuni HospitalOstuni BRItaly Radiation Oncology InstituteCampus Biomedico UniversityRomeItaly Pediatric Gastroenterology UnitSacred Heart UniversityPoliclinico GemelliRomeItaly 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2018年第7卷第3期

页      面：192-194页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：carcinoma liver for 

摘      要：Among the 3 sub-types of cholangiocarcinoma (CH), [intrahepatic CH, hylar (CH) and extrahepatic (CH)], intrahepatic cholangiocarcinoma (ICC) accounts for up 8–10% of cholangiocarcinomas and 10–20% of all primary liver tumors (1).